Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Adenocarcinoma and EPHA5[original query] |
---|
Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas. Human pathology 2019 Nov . Setia Namrata, Wanjari Pankhuri, Yassan Lindsay, Niu Nifang, Kadri Sabah, Ritterhouse Lauren, Misdraji Joseph, Brown Ian, Segal Jeremy, Hart Jo |
EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma. Cancer gene therapy 2020 8 28 (7-8): 864-874. Huang Weimei, Lin Anqi, Luo Peng, Liu Yuchen, Xu Wentao, Zhu Weiliang, Wei Ting, Lyu Qingwen, Guo Linlang, Zhang Ji |
EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma. Aging 2020 Dec 12 . Chen Zhiming, Chen Ji, Ren Dandan, Zhang Jiao, Yang Ying, Zhang Henghui, Mao Beibei, Ma Hait |
Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases. Pathology, research and practice 2021 Nov 229 153652. Sun Hui, Li Xiaoli, Zhang Jianguo, Liu Yif |
Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data. Frontiers in immunology 2023 3 14 1090838. Li Mengyuan, Gao Xuejiao, Wang Xiaoshe |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: